Showing results (101-110 of 163) with videos related to
Sort By:
Pageof 17
Bone|October 19, 2019
Clinical effectiveness of denosumab, raloxifene, romosozumab, and teriparatide for the prevention of osteoporotic fragility fractures: A systematic review and network meta-analysisE L Simpson, Marrissa Martyn-St James, Jean Hamilton, et al.Pharmacoeconomics|March 21, 2013
Bivalirudin for the treatment of ST-segment elevation myocardial infarction: a NICE single technology appraisalE L Simpson, P Fitzgerald, P Evans, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|December 8, 2023
Early intervention and disease modification in atopic dermatitis-the current state of the field and barriers to progressM E Jacobson, R S Seshadri, R Morimoto, et al.The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|March 14, 2001
The effects of age, body mass index, smoking and general health on the risk of venous thromboembolism in users of combined oral contraceptivesA L Nightingale, R A Lawrenson, E L Simpson, et al.The British Journal of Dermatology|July 18, 2015
Assessment of atopic dermatitis using self-report and caregiver report: a multicentre validation studyJ I Silverberg, N Patel, S Immaneni, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|January 22, 2025
Increasing dosing intervals for biologics in atopic dermatitis-why, who, when and how?M E Jacobson, C M Boesjes, M S de Bruin-Weller, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|June 13, 2022
Facial erythema in patients with atopic dermatitis treated with Dupilumab - a descriptive study of morphology and AetiologyJ Ahn, D H Lee, C H Na, et al.Allergy|January 11, 2018
Epidemiology of atopic dermatitis in adults: Results from an international surveyS Barbarot, S Auziere, A Gadkari, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|May 15, 2023
Effect of upadacitinib on atopic hand eczema in patients with moderate-to-severe atopic dermatitis: Results from two randomized phase 3 trialsE L Simpson, K Rahawi, X Hu, et al.The British Journal of Dermatology|April 12, 2019
Validation of five patient-reported outcomes for atopic dermatitis severity in adultsJ I Silverberg, D J Margolis, M Boguniewicz, et al.Pageof 17